Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
4
×
national
national blog main
national top stories
new york blog main
4
×
new york top stories
pembrolizumab
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
gene therapy
medicare
abbvie
affordable care act
alzheimer's disease
biogen
bristol-myers squibb
cancer
clinical trials
deals
What
bio
roundup
companies
drug
nash
acquisitions
albert
american
approval
arena’s
based
best
biggest
biogen’s
biopharmaceutical
bounty
bourla
ceo
cig
comeback
company
continue
convo
corner
crash
crispr
deals
debate
delivered
earlier
expressing
failures
future
healthcare
imports
industry
ipo
kind
life
littered
Language
unknown
Current search:
merck
×
pembrolizumab
×
" new york blog main "
×
biotech
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More